Moderna stock shot up after Merck said it is exercising an option to work on a personalized cancer vaccine with the Covid-19 vaccine maker. Merck (ticker: MRK) will pay Moderna (MRNA) $250 million for...
Tag: Biotech and Pharma
An Alzheimer’s Drug’s Big Surprise: What It Means
Until this past week, there seemed to be no answers to the Alzheimer’s puzzle. The leading theory of the disease, that it was caused by a buildup of beta amyloid plaque in the brain, had been disprove...
Moderna Stock Surges. China Would Be a Big Market.
Text size Moderna stock has gotten a boost from the CEO’s comments about China. Photo by Justin Sullivan/Getty Images Moderna ’s Covid-19 vaccine has been wildly successful, but its stock has be...
Lucid, SoFi, and 3 Other SPAC Stocks Whose Downturns Might Be Ending
Text size Most SPAC-related stocks, including Virgin Galactic, haven’t been soaring in recent months. Courtesy Virgin Galactic Sometimes the best time to look for new investment ideas are when t...
The Oil Surplus Could Persist. Expect Prices to Fall
Text size This commentary was issued recently by money managers, research firms, and market newsletter writers and has been edited by Barron’s. Expect Oil Prices to Fall THINK Economic and Finan...
Weighed Down by Opioid Litigation, Endo International Files for Bankruptcy
Text size Dreamstime The generic drugmaker Endo International , which faces thousands of lawsuits related to its alleged role in the opioid crisis, filed for bankruptcy late Tuesday morning, while ann...
What Stocks Are Moving Monday? Tesla, Palantir, First Solar and More.
Text size Tesla shares rise early Monday. (Photo by Justin Sullivan/Getty Images) Stock futures were trading higher Monday with investors assessing how aggressive the Federal Reserve will be in its ef...
A Recession Is Coming. These Are the Stocks to Hunker Down In.
Eli Salzmann loves nothing better than finding a company that’s a “dog of a stock with no momentum” but on the verge of better days. At its core, that is what value investing is all about. Over the co...
Moderna’s Earnings Are Wednesday. Here’s What to Expect.
Text size Moderna is developing two vaccines for the fall, one for the U.S. and the other for international markets. Sean Gallup/Getty Images As the U.S. prepares for a broad Covid-19 booster campaign...
AbbVie Stock Slips After Earnings, Charge for Potential Opioid Deal
Text size AbbVie said it continues to expect adjusted diluted earnings of between $13.78 and $13.98 per share for the full fiscal year. Dreamstime The drugmaker AbbVie turned in quarterly earnings tha...
Inflation Reduction Act: What to Know About the Democrats’ Latest Economic Package
The bill Sen. Joe Manchin (D-W.Va.) and Majority Leader Chuck Schumer agreed to aims to address climate change, healthcare, taxes, and more. Photo by Kevin Dietsch/Getty Images Text size Build Back Be...
Merck Is Now in Advanced Talks to Buy Cancer Biotech Seagen for $40 Billion
Text size New Jersey-based Merck has a market value of more than $234 billion. Michael Vi/Dreamstime Merck & Co is in advanced talks to buy Seagen in a deal that could value the cancer biotech at...
Pfizer Raises Covid-19 Vaccine Price 27%. What It Means for the Stock.
Text size Pfizer said it has signed a deal to supply the U.S. with vaccines in the fall, while Moderna has yet to announce a sale. Jacob King – WPA Pool / Getty Images Pfizer has raised the U.S....
Novartis Will Cut 8,000 Jobs Under CEO’s Shake-Up Plan
Text size Vasant Narasimhan, CEO of Novartis. ERIC PIERMONT/AFP/Getty Images Pharmaceutical giant Novartis said Tuesday it will lay off more than 7% of its workforce, just a few months after CEO Vas N...
U.S. Stocks Poised to Open Lower on Monday Ahead of Fed Week
Stocks are poised to open lower on Monday. (Photo by Spencer Platt/Getty Images) Getty Images Text size U.S. stocks were poised for a lower opening on Monday ahead of the Federal Reserve’s decision on...
Turning Point Stock Doubles on Bristol Deal. What It Means for Biotech M&A.
Text size Photograph by Georges Gobet/AFP/Getty Images Turning Point Therapeutics stock has more than doubled after Bristol Myers Squibb announced that it had agreed to buy the company. It’s just the ...
Buy Eli Lilly Stock. Its Obesity Drug Mounjaro Will Be a Hit, Analyst Says.
Text size Eli Lily said in August that initial demand for Mounjaro was strong. Daniel Acker/Bloomberg Eli Lilly’s novel treatment for diabetes and obesity could become one of history’s bestselling dru...